Status:
COMPLETED
Factorial Study of Metoprolol Succinate TOPROL-XL (324A)
Lead Sponsor:
AstraZeneca
Conditions:
High Blood Pressure (Hypertension).
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
The purpose of this research study is to determine if treatment with the combination of metoprolol succinate and hydrochlorothiazide is more effective at lowering blood pressure than treatment with ei...
Eligibility Criteria
Inclusion
- Diastolic blood pressure between 95 and 114 mm at screening and start of treatment
Exclusion
- Significant conditions which in the opinion of the investigator place the subject at undue risk, eg Renal impairment, hepatitis
- Known secondary causes of hypertension, eg, Cushing's syndrome, renal artery stenosis, pheochromocytoma, hyperaldosteronism
- Systolic blood pressure greater or equal to 180 mm Hg at start of trial
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2004
Estimated Enrollment :
1900 Patients enrolled
Trial Details
Trial ID
NCT00642096
Start Date
June 1 2003
End Date
July 1 2004
Last Update
March 25 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.